GeneSight Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
600
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$352M
- Investors
-
1
GeneSight General Information
Description
Operator of a genetic testing laboratory intended for personalized medicine of psychiatric disorders. The company specializes in pharmacogenomics and is focused on aiding healthcare providers, thereby enabling them to collect the genetic information they need to determine the appropriate medication for individual patients dealing with neuropsychiatric and other medical conditions.
Contact Information
Website
www.genesight.com(Operating Subsidiary)
Corporate Office
- 6960 Cintas Boulevard
- Mason, OH 45040
- United States
Corporate Office
- 6960 Cintas Boulevard
- Mason, OH 45040
- United States
GeneSight Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 31-Aug-2016 | $352M | Completed | Generating Revenue | ||
| 11. Debt - General | 22-Apr-2016 | Completed | Profitable | |||
| 10. Later Stage VC (Series D) | 21-Dec-2015 | Completed | Profitable | |||
| 9. Grant | 16-Oct-2014 | Completed | Profitable | |||
| 8. Later Stage VC (Series C) | 22-May-2014 | Completed | Profitable | |||
| 7. Later Stage VC (Series B) | 31-Jan-2012 | Completed | Profitable | |||
| 6. Early Stage VC | 06-Jul-2010 | Completed | Profitable | |||
| 5. Grant | 31-Dec-2009 | Completed | Profitable | |||
| 4. Early Stage VC | 05-Jan-2009 | $2.65M | $12.5M | Completed | Profitable | |
| 3. Early Stage VC | 15-Jun-2008 | $1.6M | $9.8M | Completed | Profitable |
GeneSight Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 13,998,351 | $0.000010 | 8% | $1.04 | $1.04 | 1x | $1.04 | 33.08% |
| Series A | 5,160,725 | $0.000010 | 8% | $1 | $1 | 1x | $1 | 12.2% |
GeneSight Comparisons
Industry
Financing
Details
GeneSight Competitors (15)
One of GeneSight’s 15 competitors is DRUGSCAN, a Formerly PE-Backed company based in Horsham, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DRUGSCAN | Formerly PE-Backed | Horsham, PA | ||||
| Helix (Laboratory Services (Healthcare)) | Venture Capital-Backed | San Mateo, CA | ||||
| ARCpoint | Corporation | Greenville, SC | ||||
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| Alpha Genomix | Corporation | GA |
GeneSight Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GeneSight Patents
GeneSight Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014113522-A1 | Methods for pharmacogenomic classification | Inactive | 16-Jan-2013 | ||
| WO-2014026152-A2 | Systems and methods for pharmacogenomic decision support in psychiatry | Inactive | 10-Aug-2012 | ||
| WO-2013181256-A2 | Novel pharmacogene single nucleotide polymorphisms and methods of detecting same | Inactive | 29-May-2012 | ||
| WO-2013181256-A3 | Novel pharmacogene single nucleotide polymorphisms and methods of detecting same | Inactive | 29-May-2012 | G16B30/00 |
GeneSight Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GeneSight Former Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alafi Capital Company | Venture Capital | Minority | ||
| Allos Ventures | Venture Capital | Minority | ||
| American Financial Group | Holding Company | Minority | ||
| Blue Chip Venture Company | Venture Capital | Minority | ||
| Cincinnati Children's Hospital Medical Center | Not-For-Profit Venture Capital | Minority |
GeneSight Investments (1)
GeneSight’s most recent deal was a Later Stage VC with Neurotrack for . The deal was made on 11-Jun-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Neurotrack | 11-Jun-2019 | Later Stage VC | Decision/Risk Analysis |
GeneSight FAQs
-
When was GeneSight founded?
GeneSight was founded in 2006.
-
Where is GeneSight headquartered?
GeneSight is headquartered in Mason, OH.
-
What is the size of GeneSight?
GeneSight has 600 total employees.
-
What industry is GeneSight in?
GeneSight’s primary industry is Laboratory Services (Healthcare).
-
Is GeneSight a private or public company?
GeneSight is a Private company.
-
What is the current valuation of GeneSight?
The current valuation of GeneSight is .
-
What is GeneSight’s current revenue?
The current revenue for GeneSight is .
-
How much funding has GeneSight raised over time?
GeneSight has raised $132M.
-
Who are GeneSight’s investors?
Alafi Capital Company, Allos Ventures, American Financial Group, Blue Chip Venture Company, and Cincinnati Children's Hospital Medical Center are 5 of 23 investors who have invested in GeneSight.
-
Who are GeneSight’s competitors?
DRUGSCAN, Helix (Laboratory Services (Healthcare)), ARCpoint, Gene By Gene, and Alpha Genomix are some of the 15 competitors of GeneSight.
-
When was GeneSight acquired?
GeneSight was acquired on 31-Aug-2016.
-
Who acquired GeneSight?
GeneSight was acquired by Myriad Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
